Hydration in cancer patients.

04:33 EDT 2nd September 2015 | BioPortfolio

Summary of "Hydration in cancer patients."

PURPOSE OF
REVIEW:
To provide an overview of issues central to hydration in an oncology population while highlighting recent advances and publications in the clinical and scientific literature. RECENT
FINDINGS:
Dehydration accounts for a significant number of unplanned visits to cancer clinics and emergency rooms. The decision to provide or withhold fluid in patients with terminal cancer is strongly influenced by subjective beliefs and the decision to use of hydration at the end of life should be individualized. Chronic dehydration may play a role in the pathogenesis of cancer.
SUMMARY:
Cancer patients are at high risk for dehydration from both the disease and the treatment. Treating physicians should have a low threshold for providing additional fluids to prevent dehydration. For patients at the end of life, hydration may be indicated in select patients.

Affiliation

Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.

Journal Details

This article was published in the following journal.

Name: Current opinion in supportive and palliative care
ISSN: 1751-4266
Pages:

Links

PubMed Articles [35973 Associated PubMed Articles listed on BioPortfolio]

Short-term low-volume hydration in cisplatin-based chemotherapy for patients with lung cancer: the second prospective feasibility study in the Okayama Lung Cancer Study Group Trial 1201.

We previously reported the feasibility of short-term low-volume hydration in patients with advanced lung cancer who received cisplatin-based chemotherapy (Jpn J Clin Oncol 2013). We sought to determin...

Feasibility of Short Volume Hydration in Patients with Lung Cancer Treated with Cisplatin-Containing Chemotherapy.

The aim of this study was to examine the feasibility of short volume hydration(SH)with magnesium and mannitol versus normal high volume hydration(NH)for targeting nephrotoxicity in lung cancer patient...

Nephroprotective effects of hydration with magnesium in patients with cervical cancer receiving Cisplatin.

The present study aimed to assess the efficacy of 15 mEq magnesium supplied as part of a prehydration regimen in preventing cisplatin-induced nephrotoxicity in patients undergoing therapy with cisplat...

Some thermodynamical aspects of protein hydration water.

We study by means of nuclear magnetic resonance the self-diffusion of protein hydration water at different hydration levels across a large temperature range that includes the deeply supercooled regime...

Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection.

Procalcitonin (PCT) and Interleukin-6 (IL-6) have emerged as biomarkers for different inflammatory conditions. The purpose of the study was to evaluate the role of PCT and IL-6 as biomarkers of cancer...

Clinical Trials [6088 Associated Clinical Trials listed on BioPortfolio]

Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Hydration with a saline solution may protect kidney cells from the s...

Parenteral Hydration in Advanced Cancer Patients

The goal of this clinical research study is to learn whether being hydrated (given liquids) through a catheter in a vein or in the tissue under the skin can improve symptoms of dehydration...

Subcutaneous Recombinant Human Hyaluronidase: Workflow Analysis and Emergency Department Design

This is an observational study examining the workflow dynamics and training requirements that support effective use of subcutaneous hydration delivery (a newly FDA approved Baxter product)...

Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy (CIN) Prevention

This study is being proposed with the objective to assess the potential benefits of induced diuresis by furosemide with matched hydration therapy compared to standard hydration in the prev...

Hydration Monitor Validation in Elderly

The study will aim to determine normal daily variation of the individual hydration level in longitudinal study on elderly in assisted living facility and assess a range of variation of ind...

Medical and Biotech [MESH] Definitions

Institutions specializing in the care of cancer patients.

A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From National Cancer Institute, NIH Publication No. 91-3074, October 1990)

Test for cell-mediated antitumor immunity and related serum blocking factors based on the finding that leukocytes from cancer patients, but not from controls, when mixed in vitro with antigenic extracts of tumors of the same histological type, undergo a diminution in their normal adherence to glass surfaces. Sera from tumor-bearing patients block the LAI reaction of their own leukocytes or those of other patients with the same type of tumor.

Nursing care provided cancer patients. It includes aspects of family functioning through education of both patient and family. The specialty of oncologic nursing focuses on cancer as a major health care problem.

Assistance in managing and monitoring drug therapy for patients receiving treatment for cancer or chronic conditions such as asthma and diabetes, consulting with patients and their families on the proper use of medication; conducting wellness and disease prevention programs to improve public health; overseeing medication use in a variety of settings.


Advertisement
 

Relevant Topics

Cancer
Latest News Clinical Trials Research Drugs Reports Corporate
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Head and neck cancers
Latest News Clinical Trials Research Drugs Reports Corporate
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Cancer Disease
Latest News Clinical Trials Research Drugs Reports Corporate
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Advertisement